EW logo

Edwards Lifesciences (EW) Free cash flow

annual FCF:

$259.90M-$369.60M(-58.71%)
December 31, 2024

Summary

  • As of today (June 22, 2025), EW annual free cash flow is $259.90 million, with the most recent change of -$369.60 million (-58.71%) on December 31, 2024.
  • During the last 3 years, EW annual FCF has fallen by -$1.14 billion (-81.47%).
  • EW annual FCF is now -81.47% below its all-time high of $1.40 billion, reached on December 31, 2021.

Performance

EW Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

quarterly FCF:

$224.40M+$406.30M(+223.36%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW quarterly free cash flow is $224.40 million, with the most recent change of +$406.30 million (+223.36%) on March 1, 2025.
  • Over the past year, EW quarterly FCF has increased by +$363.20 million (+261.67%).
  • EW quarterly FCF is now -70.55% below its all-time high of $762.00 million, reached on June 30, 2014.

Performance

EW quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

TTM FCF:

$623.10M+$363.20M(+139.75%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW TTM free cash flow is $623.10 million, with the most recent change of +$363.20 million (+139.75%) on March 1, 2025.
  • Over the past year, EW TTM FCF has increased by +$371.90 million (+148.05%).
  • EW TTM FCF is now -56.38% below its all-time high of $1.43 billion, reached on March 31, 2022.

Performance

EW TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

EW Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-58.7%+261.7%+148.1%
3 y3 years-81.5%+1.7%-56.4%
5 y5 years-71.3%+79.7%-42.7%

EW Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.5%at low-37.0%+223.4%-56.4%+148.1%
5 y5-year-81.5%at low-52.4%+223.4%-56.4%+148.1%
alltimeall time-81.5%+312.5%-70.5%+223.4%-56.4%>+9999.0%

EW Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$224.40M(-223.4%)
$623.10M(+139.7%)
Dec 2024
$259.90M(-58.7%)
-$181.90M(-161.8%)
$259.90M(-47.0%)
Sep 2024
-
$294.50M(+2.9%)
$490.10M(-11.2%)
Jun 2024
-
$286.10M(-306.1%)
$551.80M(+119.7%)
Mar 2024
-
-$138.80M(-387.4%)
$251.20M(-60.1%)
Dec 2023
$629.50M(-34.0%)
$48.30M(-86.4%)
$629.50M(-18.8%)
Sep 2023
-
$356.20M(-2556.6%)
$774.90M(+15.9%)
Jun 2023
-
-$14.50M(-106.1%)
$668.70M(-31.2%)
Mar 2023
-
$239.50M(+23.6%)
$972.30M(+2.0%)
Dec 2022
$953.40M(-32.0%)
$193.70M(-22.5%)
$953.40M(-8.3%)
Sep 2022
-
$250.00M(-13.5%)
$1.04B(-17.5%)
Jun 2022
-
$289.10M(+31.1%)
$1.26B(-11.7%)
Mar 2022
-
$220.60M(-21.2%)
$1.43B(+1.9%)
Dec 2021
$1.40B(+116.7%)
$279.80M(-40.6%)
$1.40B(-0.5%)
Sep 2021
-
$471.20M(+3.2%)
$1.41B(+34.1%)
Jun 2021
-
$456.80M(+134.9%)
$1.05B(+46.6%)
Mar 2021
-
$194.50M(-32.1%)
$716.60M(+10.8%)
Dec 2020
$647.00M(-28.5%)
$286.30M(+153.8%)
$647.00M(-6.5%)
Sep 2020
-
$112.80M(-8.3%)
$692.10M(-26.4%)
Jun 2020
-
$123.00M(-1.5%)
$940.50M(-13.5%)
Mar 2020
-
$124.90M(-62.3%)
$1.09B(+20.2%)
Dec 2019
$904.50M(+32.0%)
$331.40M(-8.3%)
$904.50M(+11.9%)
Sep 2019
-
$361.20M(+34.1%)
$808.40M(+14.8%)
Jun 2019
-
$269.40M(-568.5%)
$704.40M(+34.8%)
Mar 2019
-
-$57.50M(-124.4%)
$522.40M(-23.7%)
Dec 2018
$685.00M(-17.0%)
$235.30M(-8.5%)
$685.00M(-9.2%)
Sep 2018
-
$257.20M(+194.3%)
$754.30M(-2.3%)
Jun 2018
-
$87.40M(-16.8%)
$772.00M(-5.9%)
Mar 2018
-
$105.10M(-65.5%)
$820.60M(-0.6%)
Dec 2017
$825.20M(+69.4%)
$304.60M(+10.8%)
$825.20M(+25.3%)
Sep 2017
-
$274.90M(+102.1%)
$658.50M(+21.7%)
Jun 2017
-
$136.00M(+24.0%)
$541.20M(+4.6%)
Mar 2017
-
$109.70M(-20.4%)
$517.30M(+6.2%)
Dec 2016
$487.00M(+9.9%)
$137.90M(-12.5%)
$487.00M(+18.3%)
Sep 2016
-
$157.60M(+40.6%)
$411.60M(-4.4%)
Jun 2016
-
$112.10M(+41.2%)
$430.50M(-8.4%)
Mar 2016
-
$79.40M(+27.0%)
$470.10M(+6.1%)
Dec 2015
$443.20M(-52.3%)
$62.50M(-64.6%)
$443.20M(+3.4%)
Sep 2015
-
$176.50M(+16.3%)
$428.60M(+74.1%)
Jun 2015
-
$151.70M(+189.0%)
$246.20M(-71.3%)
Mar 2015
-
$52.50M(+9.6%)
$856.50M(-7.8%)
Dec 2014
$928.60M(+156.1%)
$47.90M(-911.9%)
$928.60M(-4.3%)
Sep 2014
-
-$5.90M(-100.8%)
$970.80M(-10.6%)
Jun 2014
-
$762.00M(+511.6%)
$1.09B(+156.9%)
Mar 2014
-
$124.60M(+38.3%)
$422.90M(+16.6%)
Dec 2013
$362.60M(+47.3%)
$90.10M(-17.8%)
$362.60M(+5.7%)
Sep 2013
-
$109.60M(+11.2%)
$343.10M(+1.2%)
Jun 2013
-
$98.60M(+53.3%)
$339.10M(-5.6%)
Mar 2013
-
$64.30M(-8.9%)
$359.10M(+45.9%)
Dec 2012
$246.10M
$70.60M(-33.1%)
$246.10M(+3.6%)
Sep 2012
-
$105.60M(-11.0%)
$237.50M(+4.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$118.60M(-343.5%)
$227.80M(+30.5%)
Mar 2012
-
-$48.70M(-178.5%)
$174.50M(-22.1%)
Dec 2011
$223.90M(+18.8%)
$62.00M(-35.3%)
$223.90M(-4.4%)
Sep 2011
-
$95.90M(+46.9%)
$234.20M(+7.3%)
Jun 2011
-
$65.30M(+9228.6%)
$218.30M(+17.8%)
Mar 2011
-
$700.00K(-99.0%)
$185.30M(-1.6%)
Dec 2010
$188.40M(+86.0%)
$72.30M(-9.6%)
$188.40M(+19.0%)
Sep 2010
-
$80.00M(+147.7%)
$158.30M(+15.0%)
Jun 2010
-
$32.30M(+750.0%)
$137.70M(-9.5%)
Mar 2010
-
$3.80M(-91.0%)
$152.20M(+50.2%)
Dec 2009
$101.30M(+34.7%)
$42.20M(-29.0%)
$101.30M(+6.7%)
Sep 2009
-
$59.40M(+26.9%)
$94.90M(+155.8%)
Jun 2009
-
$46.80M(-199.4%)
$37.10M(+408.2%)
Mar 2009
-
-$47.10M(-231.6%)
$7.30M(-90.3%)
Dec 2008
$75.20M(-49.1%)
$35.80M(+2137.5%)
$75.20M(-23.2%)
Sep 2008
-
$1.60M(-90.6%)
$97.90M(-30.1%)
Jun 2008
-
$17.00M(-18.3%)
$140.00M(-4.1%)
Mar 2008
-
$20.80M(-64.4%)
$146.00M(-1.2%)
Dec 2007
$147.70M(-13.8%)
$58.50M(+33.9%)
$147.70M(+4.2%)
Sep 2007
-
$43.70M(+90.0%)
$141.80M(+1.1%)
Jun 2007
-
$23.00M(+2.2%)
$140.30M(-1.9%)
Mar 2007
-
$22.50M(-57.2%)
$143.00M(-16.6%)
Dec 2006
$171.40M(+99.8%)
$52.60M(+24.6%)
$171.40M(+23.6%)
Sep 2006
-
$42.20M(+64.2%)
$138.70M(+11.2%)
Jun 2006
-
$25.70M(-49.5%)
$124.70M(+2.4%)
Mar 2006
-
$50.90M(+155.8%)
$121.80M(+42.0%)
Dec 2005
$85.80M(-37.9%)
$19.90M(-29.4%)
$85.80M(-11.6%)
Sep 2005
-
$28.20M(+23.7%)
$97.10M(-20.0%)
Jun 2005
-
$22.80M(+53.0%)
$121.30M(-0.4%)
Mar 2005
-
$14.90M(-52.2%)
$121.80M(-11.8%)
Dec 2004
$138.10M(+32.5%)
$31.20M(-40.5%)
$138.10M(-24.7%)
Sep 2004
-
$52.40M(+124.9%)
$183.30M(+10.0%)
Jun 2004
-
$23.30M(-25.3%)
$166.60M(+19.0%)
Mar 2004
-
$31.20M(-59.2%)
$140.00M(+34.4%)
Dec 2003
$104.20M(+30.4%)
$76.40M(+114.0%)
$104.20M(+76.0%)
Sep 2003
-
$35.70M(-1181.8%)
$59.20M(+29.5%)
Jun 2003
-
-$3.30M(-28.3%)
$45.70M(-45.5%)
Mar 2003
-
-$4.60M(-114.6%)
$83.80M(+4.9%)
Dec 2002
$79.90M(+26.8%)
$31.40M(+41.4%)
$79.90M(-6.1%)
Sep 2002
-
$22.20M(-36.2%)
$85.10M(+5.8%)
Jun 2002
-
$34.80M(-509.4%)
$80.40M(+12.9%)
Mar 2002
-
-$8.50M(-123.2%)
$71.20M(+13.0%)
Dec 2001
$63.00M(-30.8%)
$36.60M(+109.1%)
$63.00M(-2.8%)
Sep 2001
-
$17.50M(-31.6%)
$64.80M(-14.6%)
Jun 2001
-
$25.60M(-253.3%)
$75.90M(+9.5%)
Mar 2001
-
-$16.70M(-143.5%)
$69.30M(-23.8%)
Dec 2000
$91.00M(-32.1%)
$38.40M(+34.3%)
$91.00M(+73.0%)
Sep 2000
-
$28.60M(+50.5%)
$52.60M(+119.2%)
Jun 2000
-
$19.00M(+280.0%)
$24.00M(+380.0%)
Mar 2000
-
$5.00M
$5.00M
Dec 1999
$134.00M
-
-

FAQ

  • What is Edwards Lifesciences annual free cash flow?
  • What is the all time high annual FCF for Edwards Lifesciences?
  • What is Edwards Lifesciences annual FCF year-on-year change?
  • What is Edwards Lifesciences quarterly free cash flow?
  • What is the all time high quarterly FCF for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly FCF year-on-year change?
  • What is Edwards Lifesciences TTM free cash flow?
  • What is the all time high TTM FCF for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM FCF year-on-year change?

What is Edwards Lifesciences annual free cash flow?

The current annual FCF of EW is $259.90M

What is the all time high annual FCF for Edwards Lifesciences?

Edwards Lifesciences all-time high annual free cash flow is $1.40B

What is Edwards Lifesciences annual FCF year-on-year change?

Over the past year, EW annual free cash flow has changed by -$369.60M (-58.71%)

What is Edwards Lifesciences quarterly free cash flow?

The current quarterly FCF of EW is $224.40M

What is the all time high quarterly FCF for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly free cash flow is $762.00M

What is Edwards Lifesciences quarterly FCF year-on-year change?

Over the past year, EW quarterly free cash flow has changed by +$363.20M (+261.67%)

What is Edwards Lifesciences TTM free cash flow?

The current TTM FCF of EW is $623.10M

What is the all time high TTM FCF for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM free cash flow is $1.43B

What is Edwards Lifesciences TTM FCF year-on-year change?

Over the past year, EW TTM free cash flow has changed by +$371.90M (+148.05%)
On this page